Xcel Wealth Management, LLC Merck & Co., Inc. Transaction History

Xcel Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$73.51 - $82.4 $407,318 - $456,578	-5,541 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$72.28 - $90.54 $963,853 - $1.21 Million	-13,335 Reduced 70.65%	5,541 $425,000
Q3 2021 Oct 21, 2021	BUY	$71.68 - $78.83 $247,296 - $271,963	3,450 Added 22.36%	18,876 $1.42 Million
Q2 2021 Jul 15, 2021	SELL	$70.31 - $77.77 $106,589 - $117,899	-1,516 Reduced 8.95%	15,426 $1.2 Million
Q1 2021 Apr 15, 2021	BUY	$68.86 - $81.11 $604,246 - $711,740	8,775 Added 107.44%	16,942 $1.31 Million
Q4 2020 Jan 13, 2021	BUY	$71.77 - $79.65 $401,481 - $445,562	5,594 Added 217.41%	8,167 $668,000
Q3 2020 Oct 27, 2020	BUY	$73.18 - $82.95 $188,292 - $213,430	2,573 New	2,573 $213,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Xcel Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Xcel Wealth Management, LLC with notifications on news.